Thousands of Britons using the weight loss drug Ozempic may be inadvertently risking their travel insurance, industry experts warn.
Chief executives in the insurance sector say many customers are unaware that Ozempic can be classified as medication for a pre-existing condition.
Failing to declare it properly could be considered misrepresentation, potentially leading insurers to void policies.
The issue affects both travel and health insurance, highlighting the importance of full disclosure when purchasing coverage.
Experts urge users of Ozempic and similar treatments to carefully review policy definitions and notify insurers to avoid unexpected gaps in protection.
Related topics:
- Study Finds Gen Z Adults Least Likely to Pay for Health Insurance
- Vietnam Slashes Student Health Insurance Costs by Nearly 40% in New Decree
- Group Life Insurance Premiums on the Rise Amidst Industry Challenges